Hello! I hope everyone is having a safe Holiday Season!
This current blog will stick with the big topic of 2020, we have discussed Covid-19 coding and billing many, many times in 2020, but with the rapidly progressing research, Covid-19 education is ever advancing. We will be discussing the newly approved Covid-19 vaccine with regard to medical coding services and offshore medical billing.
Below is a grid obtained from the CMS.gov website with the CPT codes along with the payment allowances, as of the writing of this blog (12/14/2020) the effective dates have not been updated. As of now Medicare will cover the cost of the Covid-19 vaccine as well as the administration and will waive the out-of-pocket costs. Medicare will pay $16.95 for the first dose of the vaccine and $28.39 for the second dose of the vaccine.
Payment Allowances and Effective Dates for COVID-19 Vaccines and their Administration during the Public Health Emergency:
Code |
CPT Short Descriptor |
Labeler Name |
Vaccine/Procedure Name |
Payment Allowance |
Effective Dates |
91300 |
SARSCOV2 VAC 30MCG/0.3ML IM |
Pfizer |
Pfizer-Biontech Covid-19 Vaccine |
$0.010* |
xx/xx/xxxx – TBD |
0001A |
ADM SARSCOV2 30MCG/0.3ML 1ST |
Pfizer |
Pfizer-Biontech Covid-19 Vaccine Administration – First Dose |
$16.940** |
xx/xx/xxxx – TBD |
0002A |
ADM SARSCOV2 30MCG/0.3ML 2ND |
Pfizer |
Pfizer-Biontech Covid-19 Vaccine Administration – Second Dose |
$28.390** |
xx/xx/xxxx – TBD |
91301 |
SARSCOV2 VAC 100MCG/0.5ML IM |
Moderna |
Moderna Covid-19 Vaccine |
$0.010* |
xx/xx/xxxx – TBD |
0011A |
ADM SARSCOV2 100MCG/0.5ML1ST |
Moderna |
Moderna Covid-19 Vaccine Administration – First Dose |
$16.940** |
xx/xx/xxxx – TBD |
0012A |
ADM SARSCOV2 100MCG/0.5ML2ND |
Moderna |
Moderna Covid-19 Vaccine Administration – Second Dose |
$28.390** |
xx/xx/xxxx – TBD |
* Since we anticipate that providers, initially, will not incur a cost for the product, CMS will update the payment allowance at a later date. Providers should not bill for the product if they received it for free.
** These rates will also be geographically adjusted for many providers. Certain settings utilize other payment methodologies, such as payment based on reasonable costs.
Also, to mention, we have Medical coding Services and payment allowances for Monoclonal Antibodies. According to FDA.gov:
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses. Bamlanivimab is a monoclonal antibody that is specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’s attachment and entry into human cells. Nov 9, 2020
Code |
CPT Short Descriptor |
Labeler Name |
Vaccine/Procedure Name |
Payment Allowance |
Effective Dates |
Q0239 |
bamlanivimab-xxxx |
Eli Lilly |
Injection, bamlanivimab, 700 mg |
$0.010* |
11/10/2020 – TBD |
M0239
|
bamlanivimab-xxxx infusion |
Eli Lilly |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
$309.600*** |
11/10/2020 – TBD |
Q0243 |
casirivimab and imdevimab |
Regeneron |
Injection, casirivimab and imdevimab, 2400 mg |
$0.010* |
11/21/2020 – TBD |
M0243 |
casirivi and imdevi infusion |
Regeneron |
intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring |
$309.600*** |
11/21/2020 – TBD |
Payment Allowances and Effective Dates for COVID-19 Monoclonal Antibodies and their Administration during the Public Health Emergency:
* Since we anticipate that providers, initially, will not incur a cost for the product, CMS will update the payment allowance at a later date. Providers should not bill for the product if they received it for free.
*** Medicare will pay a rate of $309.60 for many providers. These rates will also be geographically adjusted for many providers. Certain settings utilize other payment methodologies, such as payment based on reasonable costs.
AAFP provides the following guidelines for coding an E&M service during the same encounter as the vaccine:
If you administer the vaccine during a significant, separately identifiable evaluation and management (E/M) service, such as an office visit, and you document the work of that E/M service, you may report an E/M code in addition to the codes for the vaccine (if applicable) and its administration. Be sure to append modifier 25 (Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service) to the E/M code in this situation. The usual cost-sharing will apply to the E/M service in this case.
As an additional note, you may want to consider adding CPT 99072 to report additional expenses incurred during the COVID 19 Public Health Emergency (PHE), this code became effective September 8, 2020.
(Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency as defined by law, due to respiratory-transmitted infectious disease.)
References: